A critical review on therapeutic approaches of CRISPR-Cas9 in diabetes mellitus.
Naunyn Schmiedebergs Arch Pharmacol
; 396(12): 3459-3481, 2023 12.
Article
in En
| MEDLINE
| ID: mdl-37522916
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Diabetes Mellitus
/
CRISPR-Cas Systems
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Naunyn Schmiedebergs Arch Pharmacol
Year:
2023
Document type:
Article
Affiliation country:
India
Country of publication:
Germany